Harmony Biosciences Holdings Inc (HRMY) stock is lower by -51.44% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives HRMY stock a score of 31 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 8. HRMY's rank also includes a long-term technical score of 12.
HRMY has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on HRMY!
Harmony Biosciences Holdings Inc (HRMY) stock has gained 2.44% while the S&P 500 has risen 0.46% as of 11:45 AM on Wednesday, Nov 22. HRMY has risen $0.67 from the previous closing price of $27.47 on volume of 83,358 shares. Over the past year the S&P 500 has gained 13.87% while HRMY is lower by -51.44%. HRMY earned $2.47 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 11.42.
Click Here to get the full Stock Report for Harmony Biosciences Holdings Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
